Clinical trial
Anti-aging and Anti-oxidant Efficacy Evaluation of the MelaGene
NCT05191056 is registered in ClinicalTrials.gov with TCI Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Anti-aging and Anti-oxidant Efficacy Evaluation of the MelaGene
- Lead sponsor
- TCI Co., Ltd.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 15, 2021
- Completion date
- February 28, 2022
- Enrollment
- 51 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
aging, antioxidative stress